325 related articles for article (PubMed ID: 2484905)
1. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
Ochi Y; Hamazu M; Kajita Y; Nagata A
Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
4. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
[TBL] [Abstract][Full Text] [Related]
5. Abnormal thyrotropin-binding immunoglobulins in two patients with Graves' disease.
Akamizu T; Ishii H; Mori T; Ishihara T; Ikekubo K; Imura H
J Clin Endocrinol Metab; 1984 Aug; 59(2):240-5. PubMed ID: 6145722
[TBL] [Abstract][Full Text] [Related]
6. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
[TBL] [Abstract][Full Text] [Related]
7. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
8. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
9. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
Iitaka M; Tanikawa T; Sakatsume Y; Yanagisawa M; Hara Y; Ishii J
Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
[TBL] [Abstract][Full Text] [Related]
10. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
[TBL] [Abstract][Full Text] [Related]
11. Anti-TSH antibodies in Graves' disease and their failure to interact with TSH receptor antibodies.
Ochi Y; Nagamune T; Nakajima Y; Ishida M; Kajita Y; Hachiya T; Ogura H
Acta Endocrinol (Copenh); 1989 Jun; 120(6):773-7. PubMed ID: 2567103
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
13. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
14. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
16. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174
[TBL] [Abstract][Full Text] [Related]
17. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
[TBL] [Abstract][Full Text] [Related]
19. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data.
Saiki Y; Ishihara T; Ikekubo K; Mori T
Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557
[TBL] [Abstract][Full Text] [Related]
20. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
Davies TF; Platzer M
Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]